JP2004514686A - 組成物と方法 - Google Patents

組成物と方法 Download PDF

Info

Publication number
JP2004514686A
JP2004514686A JP2002545645A JP2002545645A JP2004514686A JP 2004514686 A JP2004514686 A JP 2004514686A JP 2002545645 A JP2002545645 A JP 2002545645A JP 2002545645 A JP2002545645 A JP 2002545645A JP 2004514686 A JP2004514686 A JP 2004514686A
Authority
JP
Japan
Prior art keywords
per day
vitamin
composition
cognitive decline
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002545645A
Other languages
English (en)
Japanese (ja)
Inventor
ズィッカー，スティーヴン・カーティス
ウェデキンド，カレン・ジェイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/922,633 external-priority patent/US20020052402A1/en
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of JP2004514686A publication Critical patent/JP2004514686A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2002545645A 2000-10-31 2001-10-30 組成物と方法 Pending JP2004514686A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24451100P 2000-10-31 2000-10-31
US25344600P 2000-11-28 2000-11-28
US25344700P 2000-11-28 2000-11-28
US09/922,633 US20020052402A1 (en) 2000-10-31 2001-08-06 Composition and method
PCT/US2001/048665 WO2002043666A2 (en) 2000-10-31 2001-10-30 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function

Publications (1)

Publication Number Publication Date
JP2004514686A true JP2004514686A (ja) 2004-05-20

Family

ID=27500158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002545645A Pending JP2004514686A (ja) 2000-10-31 2001-10-30 組成物と方法

Country Status (6)

Country Link
EP (1) EP1339404A2 (zh)
JP (1) JP2004514686A (zh)
CN (1) CN1477958A (zh)
AU (1) AU2002232616A1 (zh)
CA (1) CA2427470A1 (zh)
WO (1) WO2002043666A2 (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521408A (ja) * 2004-11-24 2008-06-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における生体異物物質の肝臓クリアランスを改良する方法
JP2008521819A (ja) * 2004-11-24 2008-06-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における免疫応答を増大させる方法
WO2008099469A1 (ja) * 2007-02-14 2008-08-21 Tohoku University 赤血球の脂質過酸化を抑制するための組成物および方法
JP2012515211A (ja) * 2009-01-14 2012-07-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物において肝および免疫機能を向上させるための方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005185188A (ja) * 2003-12-25 2005-07-14 Nichirei Corp アセロラ処理物およびｌ−カルニチン含有組成物
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
AU2006279429B2 (en) * 2005-08-17 2010-02-25 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
CN1895671B (zh) * 2005-12-08 2012-11-28 淮北辉克药业有限公司 治疗病毒型肝病的复方制剂
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
EP2923582B1 (en) * 2009-07-14 2018-03-21 Hill's Pet Nutrition, Inc. Pet food compositions including sustained-release lipoic acid
EP2508179A1 (en) 2011-04-05 2012-10-10 Lonza Ltd. Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
CN103491954A (zh) 2011-04-05 2014-01-01 隆萨有限公司 L-肉碱、其盐及衍生物用于降低或预防疲劳和改善认知功能的用途
NL2024431B1 (en) * 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06199690A (ja) * 1992-03-06 1994-07-19 Yunie:Kk 脳代謝促進・脳機能改善剤
DE4343592C2 (de) * 1993-12-21 1998-04-16 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure und dessen Metaboliten in Form der freien Säure oder als Salze oder Ester oder Amide zur Behandlung von Glukosestoffwechselstörungen des zentralen Nervensystems
FR2721516B1 (fr) * 1994-06-27 1996-09-13 Inst Rech Biolog Sa Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
AU3287200A (en) * 1999-03-16 2000-10-04 Merck Patent Gmbh Composition comprising isoquercetin and ascorbic acid in a sustained release form
AU3913800A (en) * 1999-03-26 2000-10-16 Lipogenics, Inc. Novel antioxidant formulations and methods for using them
DE19920316A1 (de) * 1999-05-03 1999-12-09 Heinz Kiefer Arzneimittel als Antioxidans mit einer Vitamin-Spurenelement-Kombination zur Förderung der Funktionstüchtigkeit der Zellen
US6646013B1 (en) * 1999-06-15 2003-11-11 Nutri-Logics Nutrient formulations for disease reduction
WO2001032168A1 (en) * 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
CA2399319A1 (en) * 2000-01-25 2001-08-16 Nathan D. Hamilton Nutritional supplements for aged pets
HU227182B1 (en) * 2000-03-06 2010-09-28 Andras Javor Lecitin-ascorbic acid combination

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521408A (ja) * 2004-11-24 2008-06-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における生体異物物質の肝臓クリアランスを改良する方法
JP2008521819A (ja) * 2004-11-24 2008-06-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における免疫応答を増大させる方法
WO2008099469A1 (ja) * 2007-02-14 2008-08-21 Tohoku University 赤血球の脂質過酸化を抑制するための組成物および方法
JPWO2008099469A1 (ja) * 2007-02-14 2010-05-27 株式会社プロジェクト・エム 赤血球の脂質過酸化を抑制するための組成物および方法
JP2012515211A (ja) * 2009-01-14 2012-07-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物において肝および免疫機能を向上させるための方法

Also Published As

Publication number Publication date
WO2002043666A2 (en) 2002-06-06
CN1477958A (zh) 2004-02-25
EP1339404A2 (en) 2003-09-03
CA2427470A1 (en) 2002-06-06
WO2002043666A3 (en) 2003-01-30
AU2002232616A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
US6335361B1 (en) Method of treating benign forgetfulness
US6323188B1 (en) Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
JP2004514686A (ja) 組成物と方法
ES2336305T3 (es) Composicion y metodo.
WO2001021208A1 (en) Nutritional supplement for increased energy and stamina
ZA200600203B (en) Multivitamin syrup for children or young adults
JP2008214338A (ja) 高次脳機能低下改善剤および遅延記憶低下改善剤
EP4364801A2 (en) Optimised dosage of diaminophenothiazines in populations
US20140045874A1 (en) Prevention of alcohol reaction with dietary supplements
Goebels et al. Dementia associated with vitamin B12 deficiency: presentation of two cases and review of the literature
WO2002007768A1 (en) Dietary supplement compositions
BR112020016923A2 (pt) Método para reverter ou atenuar lesão, ou fraqueza ou perda óssea, ou para evitar fraturas em um indivíduo, e, composição
US6919330B2 (en) Formulations of drugs
CN118178404A (zh) 氨基酸补充剂在提高肌肉蛋白质合成中的用途
US20020076469A1 (en) Composition and method
US20020052402A1 (en) Composition and method
AU2010206791B2 (en) A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
Koll et al. Chronic α-tocopherol supplementation in rats does not ameliorate either chronic or acute alcohol-induced changes in muscle protein metabolism
ZA200303749B (en) Compositions containing an antioxidant such as alpha lipoic acid, carnitine, Vitamin C or Vitamin E for preventing or inhibiting loss of cognitive function.
Lalić-Popović et al. Comparison of formulation characteristics of drugs and dietary supplements containing alpha-lipoic acid relevant to therapeutic efficacy.
JP2005170834A (ja) 皮膚改善製剤
US20200215149A1 (en) N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
US20020077349A1 (en) Method of treating age-related vision impairment
ES2375391B1 (es) Composición de complemento nutricional.
Tanaka et al. Effect of Vitamin E Deficiency on Inhibition of Liver Regeneration by Long‐Term Administration of Alcohol

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041029

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080313

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080613

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080806